Zobrazeno 1 - 10
of 35
pro vyhledávání: '"O A Klochkova"'
Autor:
A. L. Kurenkov, O. A. Klochkova, B. I. Bursagova, L. M. Kuzenkova, A. R. Artemenko, I. V. Falkovsky
Publikováno v:
Медицинский совет, Vol 0, Iss 1S, Pp 113-121 (2017)
Injections of botulinum toxin type A (BTA) are regarded as one of the basic methods to treat cerebral palsy (CP). The article discusses issues unique mechanism of action of botulinum toxin type A injections, double sensomotor mechanism of action of t
Externí odkaz:
https://doaj.org/article/d5666562bf6d4bf5b8f4167125496e53
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 10, Iss 1, Pp 27-34 (2017)
We analyzed the dependence of the operative memory (OP) capacityon P300 parameters in healthy individuals and patientswith a varying degree of memory impairments. Our findingsdemonstrated a strong correlation between the OP capacity andthe P300 laten
Externí odkaz:
https://doaj.org/article/2040b060c4274f128736b06f6e66d68b
Autor:
A. L. Kurenkov, S. S. Nikitin, A. R. Artemenko, B. I. Bursagova, L. M. Kuzenkova, S. A. Petrova, O. A. Klochkova, A. M. Mamedyarov
Publikováno v:
Нервно-мышечные болезни, Vol 0, Iss 3, Pp 40-48 (2015)
Cerebral palsy (CP) is one of the most serious outcomes of the perinatal lesion of central nervous system and the most common reason for neurological disability in children. Being the key cause of pathological dynamic stereotypes that frequently resu
Externí odkaz:
https://doaj.org/article/899b498435284cfc9d2ec0a9786432f4
Publikováno v:
Нервно-мышечные болезни, Vol 0, Iss 1, Pp 54-61 (2015)
The article presents a rare case of a child with a laboratory confirmed combination of several inherited diseases: cystic fibrosis (mutations F508del and E92K) and facioscapulohumeral progressive muscular dystrophy (FSHD). Through the example of the
Externí odkaz:
https://doaj.org/article/b43300b48a5648a1a1a55e5ff76ceae5
Autor:
A. L. Kurenkov, O. A. Klochkova, B. I. Bursagova, L. M. Kuzenkova, Kh. M. Karimova, A. M. Mamedyarov, A. R. Artemenko, S. A. Petrova
Publikováno v:
Нервно-мышечные болезни, Vol 0, Iss 3, Pp 28-41 (2015)
Botulinum toxin type A (BoNT-A) is used in cerebral palsy (CP) for more than 20 years. Nevertheless, the unified protocol of injections and doses does not exist by now. The correct selection of target muscles for BoNT-A injections is based on the exp
Externí odkaz:
https://doaj.org/article/e645140aa7544a6b948e33aef57b3b26
Autor:
G A Shabanov, O I Klochkova
Publikováno v:
Nacionalʹnyj Psihologičeskij Žurnal, Vol 1, Iss 37, Pp 78-93 (2020)
Background. Registration and analysis of bioelectric activity of the brain while performing the mental task allows us to obtain objective information about the physiological processes of the brain. The Objective of the paper is to analyse session dyn
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 120(12)
To evaluate the most typical target muscles and dosages for the first and repeated botulinum toxin A (BTA) injections in cerebral palsy (CP) patients with severe motor deficit - GMFCS IV-V.A retrospective analysis of 677 protocols of the first and re
Autor:
V. V. Gnezditskiy, O. I. Klochkova
Publikováno v:
Human Physiology. 44:15-23
Cognitive potentials measured in players during computer games were used as a tool to assess the number of possible cognitive requests (NPCR) between two mouse clicks. The data obtained in recording cognitive evoked potentials (EP) with pressing a bu
Autor:
A. L. Kurenkov, O. A. Klochkova
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 119(2)
Botulinum toxin A (BTA) injections are an effective method of spasticity treatment in cerebral palsy (CP) but still there are a lot of questions about the selection of target muscles. The article summarizes currently accepted approaches to the goal s
Autor:
O. A. Klochkova, A. L. Kurenkov, K. M. Karimova, B. I. Bursagova, L. S. Namazova-Baranova, A. M. Mamedyarov, L. M. Kuzenkova, I. M. Tardova, I. V. Fal’kovskiy, O. G. Dontzov, M. A. Ryzhenkov, V. A. Zmanovskaya, M. N. Butorina, O. L. Pavlova, N. N. Harlamova, D. M. Dankov, E. V. Levitina, D. A. Popkov, S. O. Ryabykh, S. N. Medvedeva, E. B. Gubina, L. N. Vladykina, V. M. Kenis, T. I. Kiseleva, D. A. Krasavina, O. N. Vasil’eva, A. S. Nosko, V. P. Zykov, V. I. Michnovich, T. A. Belogorova, L. V. Rychkova
Publikováno v:
Pediatričeskaâ Farmakologiâ, Vol 13, Iss 3, Pp 259-269 (2016)
Background : The contemporary application of Botulinum toxin A (BTA) in cerebral palsy (CP) implies multilevel injections both in on-label and off-label muscles. However, there is no single international opinion on the effective and safe dosages, tar